The evaluation of emerging trends in mechanical circulatory assistance

Joseph DeRose, Mehmet C. Oz

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Acute mechanical circulatory support in the form of intra-aortic balloon counterpulsation and temporary external ventricular assist device support have proven beneficial in the stabilization of patients with acute cardiogenic shock. With recent developments in implantable left ventricular assist devices (LVADs), medium-term outpatient support as a bridge to transplantation is now possible with a survival of 75% to 80%. The evolution of society's acceptance of chronic LVAD support as well as the institution of insurance reimbursement has allowed such treatment to emerge as the state of the art for patients with end-stage heart failure awaiting cardiac transplantation. The success of outpatient LVAD support has led to trials evaluating such mechanical assistance as a destination therapy for those patients who are not candidates for transplantation. Recent developments in device designs promise to create totally implantable systems that might serve as alternative permanent treatment options for patients with end-stage heart disease.

Original languageEnglish (US)
Pages (from-to)379-385
Number of pages7
JournalCurrent Opinion in Critical Care
Volume3
Issue number5
StatePublished - 1997
Externally publishedYes

Fingerprint

Heart-Assist Devices
Outpatients
Transplantation
Counterpulsation
Equipment Design
Cardiogenic Shock
Heart Transplantation
Insurance
Heart Diseases
Therapeutics
Heart Failure
Survival

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

The evaluation of emerging trends in mechanical circulatory assistance. / DeRose, Joseph; Oz, Mehmet C.

In: Current Opinion in Critical Care, Vol. 3, No. 5, 1997, p. 379-385.

Research output: Contribution to journalArticle

@article{ede2b9d0524246609b1a98c38b66f60a,
title = "The evaluation of emerging trends in mechanical circulatory assistance",
abstract = "Acute mechanical circulatory support in the form of intra-aortic balloon counterpulsation and temporary external ventricular assist device support have proven beneficial in the stabilization of patients with acute cardiogenic shock. With recent developments in implantable left ventricular assist devices (LVADs), medium-term outpatient support as a bridge to transplantation is now possible with a survival of 75{\%} to 80{\%}. The evolution of society's acceptance of chronic LVAD support as well as the institution of insurance reimbursement has allowed such treatment to emerge as the state of the art for patients with end-stage heart failure awaiting cardiac transplantation. The success of outpatient LVAD support has led to trials evaluating such mechanical assistance as a destination therapy for those patients who are not candidates for transplantation. Recent developments in device designs promise to create totally implantable systems that might serve as alternative permanent treatment options for patients with end-stage heart disease.",
author = "Joseph DeRose and Oz, {Mehmet C.}",
year = "1997",
language = "English (US)",
volume = "3",
pages = "379--385",
journal = "Current Opinion in Critical Care",
issn = "1070-5295",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - The evaluation of emerging trends in mechanical circulatory assistance

AU - DeRose, Joseph

AU - Oz, Mehmet C.

PY - 1997

Y1 - 1997

N2 - Acute mechanical circulatory support in the form of intra-aortic balloon counterpulsation and temporary external ventricular assist device support have proven beneficial in the stabilization of patients with acute cardiogenic shock. With recent developments in implantable left ventricular assist devices (LVADs), medium-term outpatient support as a bridge to transplantation is now possible with a survival of 75% to 80%. The evolution of society's acceptance of chronic LVAD support as well as the institution of insurance reimbursement has allowed such treatment to emerge as the state of the art for patients with end-stage heart failure awaiting cardiac transplantation. The success of outpatient LVAD support has led to trials evaluating such mechanical assistance as a destination therapy for those patients who are not candidates for transplantation. Recent developments in device designs promise to create totally implantable systems that might serve as alternative permanent treatment options for patients with end-stage heart disease.

AB - Acute mechanical circulatory support in the form of intra-aortic balloon counterpulsation and temporary external ventricular assist device support have proven beneficial in the stabilization of patients with acute cardiogenic shock. With recent developments in implantable left ventricular assist devices (LVADs), medium-term outpatient support as a bridge to transplantation is now possible with a survival of 75% to 80%. The evolution of society's acceptance of chronic LVAD support as well as the institution of insurance reimbursement has allowed such treatment to emerge as the state of the art for patients with end-stage heart failure awaiting cardiac transplantation. The success of outpatient LVAD support has led to trials evaluating such mechanical assistance as a destination therapy for those patients who are not candidates for transplantation. Recent developments in device designs promise to create totally implantable systems that might serve as alternative permanent treatment options for patients with end-stage heart disease.

UR - http://www.scopus.com/inward/record.url?scp=1842739594&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842739594&partnerID=8YFLogxK

M3 - Article

VL - 3

SP - 379

EP - 385

JO - Current Opinion in Critical Care

JF - Current Opinion in Critical Care

SN - 1070-5295

IS - 5

ER -